Late Breaking Abstract - Idiopathic Pulmonary Fibrosis – a worldwide review of ‘real’ life’ practice: experience from a treatment feasibility review in 41 countries
M. Wijsenbeek (Rotterdam, Netherlands), F. Floricel (Mechelen, Belgium), J. Thonnard (Mechelen, Belgium), A. Fieuw (Mechelen, Belgium), P. Ford (Mechelen, Belgium), E. Santermans (Mechelen, Belgium), C. Vandenrijn (Mechelen, Belgium), T. Maher (London, United Kingdom)
Source: International Congress 2018 – ILDs: From bench to bedside
Session: ILDs: From bench to bedside
Session type: Oral Presentation
Number: 263
Disease area: Interstitial lung diseases
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Wijsenbeek (Rotterdam, Netherlands), F. Floricel (Mechelen, Belgium), J. Thonnard (Mechelen, Belgium), A. Fieuw (Mechelen, Belgium), P. Ford (Mechelen, Belgium), E. Santermans (Mechelen, Belgium), C. Vandenrijn (Mechelen, Belgium), T. Maher (London, United Kingdom). Late Breaking Abstract - Idiopathic Pulmonary Fibrosis – a worldwide review of ‘real’ life’ practice: experience from a treatment feasibility review in 41 countries. 263
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you: